Increases in Serum Autoantibodies Following Left Ventricular Assist Device Implantation

Left ventricular assist devices (LVADs) can serve as a bridge to transplant and/or destination therapy for patients with advanced heart failure. Implantation of LVADs is known to be associated with increases in anti-HLA antibodies, but less is known about how autoantibody levels change with these devices.

Source: Journal of Cardiac Failure - January 7, 2019 Category: Cardiology Authors: Liza Grosman-Rimon, Prabjit Ajrawat, Jocelyn Lioe, Laura C. Tumiati, Vivek Rao, Filio Billia, Andrzej Chruscinski Tags: Brief Report Source Type: research